Terazosin dimer impurity dihydrochloride
Code | Size | Price |
---|
TAR-T37817-5mg | 5mg | £314.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T37817-10mg | 10mg | £487.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Terazosin dimer impurity dihydrochloride, a dimer of Terazosin, is an impurity of Terazosin. Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist[1].
CAS:
1486464-41-8
Formula:
C24H30Cl2N8O4
Molecular Weight:
565.45
Purity:
0.98
SMILES:
NC1=C2C=C(OC)C(OC)=CC2=NC(N3CCN(C4=NC(N)=C5C=C(OC)C(OC)=CC5=N4)CC3)=N1.[H]Cl.[H]Cl
References
Michel MC, et al. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol. 1996 Feb;16(1):21-8.